Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/2090
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrince, Miles-
dc.date.accessioned2022-06-03T01:30:55Z-
dc.date.available2022-06-03T01:30:55Z-
dc.date.issued2021-10-
dc.identifier.citationBr J Haematol . 2021 Oct;195(2):160-161en_US
dc.identifier.issn0007-1048en_US
dc.identifier.issn1365-2141en_US
dc.identifier.urihttp://hdl.handle.net/11434/2090-
dc.description.abstractLenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-up. Basset M, Kimmich CR, Schreck N, Krzykalla J, Dittrich T, Veelken K, Goldschmidt H, Seckinger A, Hose D, Jauch A, Müller-Tidow C, Benner A, Hegenbart U, Schönland SO. Br J Haematol. 2021 Oct;195(2):230-243. doi: 10.1111/bjh.17685. Epub 2021 Aug 3. PMID: 34341985en_US
dc.publisherWiley Blackwellen_US
dc.relation.urihttps://pubmed.ncbi.nlm.nih.gov/34374083/en_US
dc.subjectLenalidomideen_US
dc.subjectDexamethasoneen_US
dc.subjectImmunoglobulin Light Chain (AL) Amyloidosisen_US
dc.subjectRelapsed/Refractoryen_US
dc.subjectPredictors of Efficacyen_US
dc.subjectToxicitiesen_US
dc.subjectRD Combinationen_US
dc.subjectDepartment of Haematology, Epworth HealthCare, Melbourne, Victoria, Australiaen_US
dc.subjectCancer Services Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleA cautionary tale of the use of lenalidomide and dexamethasone for relapsed/refractory immunoglobulin light chain (AL) amyloidosis.en_US
dc.typeCommentsen_US
dc.identifier.doi10.1111/bjh.17710en_US
dc.identifier.journaltitleBritish Journal of Haematologyen_US
dc.description.affiliatesSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.en_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.